Compare MDGL & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDGL | LLYVK |
|---|---|---|
| Founded | 2011 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 7.6B |
| IPO Year | N/A | N/A |
| Metric | MDGL | LLYVK |
|---|---|---|
| Price | $559.35 | $83.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $580.77 | N/A |
| AVG Volume (30 Days) | 274.1K | ★ 479.1K |
| Earning Date | 02-25-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $740,640,000.00 | $11,218,000.00 |
| Revenue This Year | $435.63 | N/A |
| Revenue Next Year | $52.56 | $9.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 864.21 | N/A |
| 52 Week Low | $265.00 | $60.55 |
| 52 Week High | $615.00 | $102.62 |
| Indicator | MDGL | LLYVK |
|---|---|---|
| Relative Strength Index (RSI) | 46.15 | 47.63 |
| Support Level | $578.00 | $82.22 |
| Resistance Level | $598.79 | $86.13 |
| Average True Range (ATR) | 19.97 | 2.19 |
| MACD | -3.94 | 0.02 |
| Stochastic Oscillator | 32.59 | 50.13 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.